semaglutide being taken off the market FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the A proposal seeks to remove

Unable to Give Blood

Learn how it fights bacteria, disrupts biofilms, supports immune health, promotes wound healing, and why researchers see it as a promising tool against chronic infections

A Novo Nordisk spokesperson told Vox, Novo Nordisk does our best to ensure patients and health care providers are educated about the appropriate and responsible use of our medicines

long-term effects on heart attack, stroke, or cardiovascular death remain unknown

The speed of substitution reflected both the widespread use of the drug (it was among the top-selling drugs in the world) and the highly competitive nature of the generic supply chain for a product that manufacturers had been preparing to enter for years